229 related articles for article (PubMed ID: 26212119)
21. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
Sarzi-Puttini P; Atzeni F; Carrabba M
Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of metabolic syndrome for the development of cardiovascular disease in a cohort of premenopausal women with systemic lupus erythematosus.
García-Villegas EA; Lerman-Garber I; Flores-Suárez LF; Aguilar-Salinas C; Márquez González H; Villa-Romero AR
Med Clin (Barc); 2015 Apr; 144(7):289-96. PubMed ID: 25458513
[TBL] [Abstract][Full Text] [Related]
23. Prediction and management of cardiovascular outcomes in systemic lupus erythematosus.
Frostegård J
Expert Rev Clin Immunol; 2015 Feb; 11(2):247-53. PubMed ID: 25517760
[TBL] [Abstract][Full Text] [Related]
24. Atherosclerosis in Systemic Lupus Erythematosus.
Tobin R; Patel N; Tobb K; Weber B; Mehta PK; Isiadinso I
Curr Atheroscler Rep; 2023 Nov; 25(11):819-827. PubMed ID: 37768411
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular disease in lupus: insights and updates.
Knight JS; Kaplan MJ
Curr Opin Rheumatol; 2013 Sep; 25(5):597-605. PubMed ID: 23846339
[TBL] [Abstract][Full Text] [Related]
26. Atherosclerosis in systemic lupus erythematosus.
Croca S; Rahman A
Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):364-372. PubMed ID: 29224678
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients.
Yang L; Tao J; Tang X; Wang Y; He X; Xu G; Ren Y; Tu Y
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):95-101. PubMed ID: 21851424
[TBL] [Abstract][Full Text] [Related]
28. Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus.
Sandborg C; Ardoin SP; Schanberg L
Nat Clin Pract Rheumatol; 2008 May; 4(5):258-65. PubMed ID: 18349862
[TBL] [Abstract][Full Text] [Related]
29. Management of cardiovascular disease in patients with systemic lupus erythematosus.
Piranavan P; Perl A
Expert Opin Pharmacother; 2020 Sep; 21(13):1617-1628. PubMed ID: 32511034
[TBL] [Abstract][Full Text] [Related]
30. Periodontal disease as a risk factor for cardiovascular disease: suggestion of a further link in systemic lupus erythematosus.
Pessoa L; Galvão V; Santos-Neto L
Med Hypotheses; 2011 Aug; 77(2):286-9. PubMed ID: 21601991
[TBL] [Abstract][Full Text] [Related]
31. Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair?
Kaplan MJ
Transl Res; 2009 Aug; 154(2):61-9. PubMed ID: 19595437
[TBL] [Abstract][Full Text] [Related]
32. Atherosclerosis in systemic lupus erythematosus.
Sherer Y; Zinger H; Shoenfeld Y
Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
[TBL] [Abstract][Full Text] [Related]
33. The future of the treatment of systemic lupus erythematosus.
Schattner A; Naparstek Y
Clin Exp Rheumatol; 2005; 23(2):254-60. PubMed ID: 15895901
[TBL] [Abstract][Full Text] [Related]
34. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?
Nikpour M; Gladman DD; Urowitz MB
Lupus; 2013 Oct; 22(12):1243-50. PubMed ID: 24097996
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.
Ruiz-Limon P; Barbarroja N; Perez-Sanchez C; Aguirre MA; Bertolaccini ML; Khamashta MA; Rodriguez-Ariza A; Almadén Y; Segui P; Khraiwesh H; Gonzalez-Reyes JA; Villalba JM; Collantes-Estevez E; Cuadrado MJ; Lopez-Pedrera C
Ann Rheum Dis; 2015 Jul; 74(7):1450-8. PubMed ID: 24658835
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.
Wigren M; Nilsson J; Kaplan MJ
J Intern Med; 2015 Nov; 278(5):494-506. PubMed ID: 25720452
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease in systemic lupus erythematosus: A comprehensive update.
Giannelou M; Mavragani CP
J Autoimmun; 2017 Aug; 82():1-12. PubMed ID: 28606749
[TBL] [Abstract][Full Text] [Related]
38. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
Bruce IN
Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
[TBL] [Abstract][Full Text] [Related]
39. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Nived O; Sturfelt G; Truedsson L; Ivars F; Leanderson T; Bengtsson AA
Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
[TBL] [Abstract][Full Text] [Related]
40. [Cardiovascular risk profile in systemic lupus erythematosus: a cross-sectional study of 879 patients].
He CS; Shi W; Ye ZM; Liang XL; Zhang B; Liu SX
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1910-3. PubMed ID: 22126778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
